Format

Send to

Choose Destination
Pediatr Nephrol. 2009 Jun;24(6):1101-12. doi: 10.1007/s00467-008-1000-1. Epub 2008 Oct 7.

Severe hypertension in children and adolescents: pathophysiology and treatment.

Author information

1
Pediatric Hypertension Program, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA. joseph.flynn@seattlechildrens.org

Erratum in

  • Pediatr Nephrol. 2012 Mar;27(3):503-4. Dosage article in article text.

Abstract

Severe, symptomatic hypertension occurs uncommonly in children, usually only in those with underlying congenital or acquired renal disease. If such hypertension has been long-standing, then rapid blood pressure reduction may be risky due to altered cerebral hemodynamics. While many drugs are available for the treatment of severe hypertension in adults, few have been studied in children. Despite the lack of scientific studies, some agents, particularly continuous intravenous infusions of nicardipine and labetalol, are preferred in many centers. These agents generally provide the ability to control the magnitude and rapidity of blood pressure reduction and should--in conjunction with careful patient monitoring--allow the safe reduction of blood pressure and the avoidance of complications. This review provides a summary of the underlying causes and pathophysiology of acute severe hypertension in childhood as well as a detailed discussion of drug treatment and the optimal clinical approach to managing children and adolescents with acute severe hypertension.

PMID:
18839219
DOI:
10.1007/s00467-008-1000-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center